高级搜索

卡铂对A549肺癌细胞的抗癌作用及其机制的初步探讨

刘晓翌, 舒清波, 田鸿生

刘晓翌, 舒清波, 田鸿生. 卡铂对A549肺癌细胞的抗癌作用及其机制的初步探讨[J]. 肿瘤防治研究, 1995, 22(3): 147-149.
引用本文: 刘晓翌, 舒清波, 田鸿生. 卡铂对A549肺癌细胞的抗癌作用及其机制的初步探讨[J]. 肿瘤防治研究, 1995, 22(3): 147-149.
Liu Xiaoyi, . The anticancer effects of carboplatin on A_(549) lung cancer cells and its mechanism[J]. Cancer Research on Prevention and Treatment, 1995, 22(3): 147-149.
Citation: Liu Xiaoyi, . The anticancer effects of carboplatin on A_(549) lung cancer cells and its mechanism[J]. Cancer Research on Prevention and Treatment, 1995, 22(3): 147-149.

卡铂对A549肺癌细胞的抗癌作用及其机制的初步探讨

The anticancer effects of carboplatin on A_(549) lung cancer cells and its mechanism

  • 摘要: 本文观察了卡铂对A549肺癌细胞DNA合成、DNA链间交联的影响及细胞超微结构的改变。依卡铂剂量不同将实验分为A、B、C、D四组,剂量分别为20μg/ml、40μg/ml、60μg/ml、80μg/ml,另设空白对照E组。结果表明,卡铂可能是DNA模板损伤型药物,通过引起DNA交联而阻碍其复制,产生杀细胞效应。

     

    Abstract: In order to study the anticancer effects of carboplatin (CBDCA) in vitro.We have examined the inhibition of DNA synthesis,DNA interstrand cross-linking(ISC)and the changes of ultrastructure of A549 Lung cancer cells (A549 cells).Four experimental groups, named A (20ug/ml)B(40ug/ ml),C(60ug/ml) and D (80ug/ml)according to different dosage of CBDCA and one group without CBDCA as control were used. In conclusion,we demonstrate that CBDCA is a DNA breakage analog,The DNA ISC induced by CBDCA is related to the inhibition of DNA replication and cytotoxicity.

     

  • 1. canetta R, et al. Carboplatin Current status and future prospect. Cancer Treat. Rep. 1988,15:17
    2. Canetta R, et al. Carboplatin, the clinical spectrum to date. Cancer Treat. Rev. 1985,12:125
    3. Ciard DJ, et al. In vitro cultivation of human tumor establishment of cell lines derived from a series of solid tumors. J. Nat. Cancer Inst, 1973,51:1417
    4. De Jong S, et al. Detection oI DNA Cross-Links in fu-mor cells with the ethidium bromide fluorescence as-say. Int. J. Cancer, 1986,37:557
    5. Schroyens W, et al. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human fu-mor clonogenic assay. J. Cancer Res. Clin Oncol, 1990,116:392
    6. Knox RJ, et al. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedich-loroplatinum (II) and cisdiammine (1,1-cyclobutane di-carboxylato platinum (II) differ only in the kinetics of their interation with DNA. Cancer Res. 1986,46:1972
    7. Zwelling LA, et al. DNA-protein and DNA interstrand cross-linking by cis-and-trans-platinum(II) di-amminedichloride in I_iz, mouse leukemia cells and rela-tion to cytotoxicity. Cancer Res. 1979,39:365
计量
  • 文章访问数:  1034
  • HTML全文浏览量:  27
  • PDF下载量:  243
  • 被引次数: 0
出版历程
  • 刊出日期:  1995-06-04

目录

    /

    返回文章
    返回
    x 关闭 永久关闭